Oliver joined Vetter in 2021 as a Product Manager, supporting the development service for early and late clinical filling and analytics team with his extensive operational and analytical experience.
Prior to joining Vetter, he honed his product and project management skills in various manufacturing, industrial and service companies in Germany, focusing on medical devices, R&D and pharmaceuticals. Oliver holds a Master of Science in Molecular- and Microbiology from the University of Konstanz, Germany, where he also earned his PhD in Human and Environmental Toxicology.

Presentation Title: From Preclinical to Clinical: Key Steps for a Successful Transition

Abstract: The shift from preclinical to clinical development is a critical step in the development of your drug product. During this transition, you not only have to significantly upscale production of your product, but also make many new strategic decisions that will lay important groundwork for your regulatory submission, commercial production of your product, and many other key components of your product’s life cycle. Oliver Okle will help you recognize important key steps that will streamline your product's path to the clinic and help you prepare your product for long-term development and market success.

View company profile